Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KAICA Trial: IVIG vs IVIG plus cyclosporin A in severe Kawasaki disease
jRCT1091220174Completed
- Sponsor
- Coordinating Committee
- Start
- Apr 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of cyclosporine in Kawasaki disease (KD) (2 arms), sponsored by Coordinating Committee. Primary endpoint: Frequency of coronary artery aneurysms during study period. Started Apr 2014; status: completed.
02
Drugs
cyclosporine
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on jRCT1091220174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220174.